Related Experiment Video
Updated: Jul 14, 2025

Rapid Generation of Amyloid from Native Proteins In vitro
Published on: December 5, 2013
Potential of ADAM 17 Signal Peptide To Form Amyloid Aggregates in Vitro
Taniya Bhardwaj1, Rajanish Giri1
1School of Biosciences and Bioengineering, Indian Institute of Technology Mandi, VPO Kamand, Mandi, Himachal Pradesh 175075, India.
Abstract:
ADAM 17, a disintegrin and metalloproteinase 17 belonging to the adamalysin protein family, is a Zn-dependent type-I transmembrane α-secretase protein. As a major sheddase, ADAM 17 acts as an indispensable regulator of chief cellular events and controls diverse cytokines, adhesion molecules, and growth factors. The signal peptide (residues 1-17) of ADAM 17 targets the protein to the secretory pathway and gets cleaved off afterward. No other function is documented for the ADAM 17 signal peptide (ADAM 17-SP) inside the cells. Here, we have taken a reductionist approach to understand the biophysical properties of ADAM 17-SP. Aiming to understand the possibility of aggregation, we found several aggregation-prone segments in the signal peptide. We performed in vitro experiments to show that the signal peptide forms amyloid-like aggregates in buffered conditions. We also studied its aggregation in the presence of sodium tripolyphosphate and heparin to correlate with the cellular conditions, as these biomolecules are naturally present inside cells. Further, we performed seeding experiments to observe the possibility of ADAM 17-SP aggregate interaction with the Aβ42 peptide. The results suggest that its seeds escalate the aggregation kinetics of the Aβ42 peptide and form heteromeric aggregates with it. We believe this finding could further intensify the aggregation studies on other signal peptides and shed light on the potential role of these segments other than signaling.
Insights
The ADAM 17 signal peptide (ADAM 17-SP) can form amyloid-like aggregates in vitro. These aggregates can accelerate amyloid beta 42 (Aβ42) peptide aggregation, suggesting a novel role for signal peptides.
Area of Science:
- Biochemistry
- Molecular Biology
- Protein Aggregation
Background:
- ADAM 17 is a metalloproteinase crucial for cellular regulation.
- The signal peptide of ADAM 17 (ADAM 17-SP) directs proteins to the secretory pathway.
- The intracellular function of ADAM 17-SP beyond signaling is largely unknown.
Purpose of the Study:
- To investigate the biophysical properties of ADAM 17-SP.
- To determine if ADAM 17-SP can form aggregates.
- To explore the interaction of ADAM 17-SP aggregates with amyloid beta 42 (Aβ42) peptide.
Main Methods:
- In vitro aggregation assays of ADAM 17-SP.
- Aggregation studies in the presence of cellular biomolecules (sodium tripolyphosphate, heparin).
- Seeding experiments with Aβ42 peptide.
Main Results:
- ADAM 17-SP contains aggregation-prone segments.
- ADAM 17-SP forms amyloid-like aggregates under buffered conditions.
- ADAM 17-SP seeds accelerate Aβ42 aggregation and form heteromeric aggregates.
Conclusions:
- ADAM 17-SP exhibits self-aggregation properties.
- ADAM 17-SP aggregation may influence other amyloidogenic peptides like Aβ42.
- This study highlights a potential novel intracellular role for signal peptides in protein aggregation.

